How FDA’s ISTAND Initiative Supports Innovative Tools in Drug Discovery and Development

How FDA’s ISTAND Initiative Supports Innovative Tools in Drug Discovery and Development

The program has been transitioned to a permanent pathway that is designed to support innovative tools like artificial intelligence, wearables, and biomarkers in drug development and trials.

Atombeat and BioDuro Partner to Launch AI Platform for Accelerating Peptide Drug Discovery

Atombeat and BioDuro have formed a strategic partnershi […] The post Atombeat and BioDuro Partner to Launch AI Platform for Accelerating Peptide Drug Discovery first appeared on GeneOnline News. The post Atombeat and BioDuro Partner to Launch AI Platform for Accelerating Peptide Drug Discovery appeared first on GeneOnline News.

Atombeat, BioDuro to launch peptide drug discovery platform

Atombeat and BioDuro have announced a strategic partnership to launch an AI-powered platform aimed at accelerating peptide drug discovery.

Atombeat & BioDuro Launch AI Platform to Speed Peptide Discovery - AI-Tech Park

On July 30, 2025, Atombeat Inc., a leading force in AI for drug discovery, and BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), announced a strategic collaboration to an AI powered platform for accelerated peptide drug discovery. This collaboration brings together Atombeat’s in silico modeling expertise, AI-accelerated & data-driven design platform with BioDuro’s expertise in discovery chemistry…